This opinion cited by 11 cases:
John Doe 1 v. Rumsfeld , 341 F. Supp. 2d 1 ( 2004 )
Mylan Pharmaceuticals Inc. v. United States Food & Drug Administration , 789 F. Supp. 2d 1 ( 2011 )
SmithKline Beecham Corp. v. Apotex Corp. , 383 F. Supp. 2d 686 ( 2004 )
National Family Planning & Reproductive Health Ass'n v. Gonzales , 391 F. Supp. 2d 200 ( 2005 )
Novo Nordisk v. Caraco Pharmaceutical Laboratories, Ltd. , 649 F. Supp. 2d 661 ( 2009 )
In Re Gabapentin Patent Litigation , 649 F. Supp. 2d 340 ( 2009 )
Purepac Pharm Co v. Thompson, Tommy G. , 354 F.3d 877 ( 2004 )
purepac-pharmaceutical-company-v-tommy-g-thompson-secretary-of-health , 354 F.3d 877 ( 2004 )
In re: FBOP Execution Protocol Cases ( 2020 )
Mylan Pharmaceuticals Inc. v. United States Food and Drug Administration ( 2011 )
Healthy Futures of Texas v. Department of Health and Human Services ( 2018 )
